2831715-45-6

Brorphine-d7 (exempt preparation) (Item No. 38145) is intended for use as an internal standard for the quantification of brorphine (Item Nos. 34184 | 27816) by GC- or LC-MS. Brorphine is categorized as an opioid.1,2 It induces respiratory depression in mice.2 Brorphine-d7 is regulated as a Schedule I compound in the United States. Brorphine-d7 (exempt preparation) (Item No. 38145) is provided as a DEA exempt preparation. This product is intended for research and forensic applications.WARNING This product is not for human or veterinary use.

Brorphine-d7 (Item No. 31566) is intended for use as an internal standard for the quantification of brorphine (Item Nos. 34184 | 27816) by GC- or LC-MS. Brorphine is categorized as an opioid.1,2 It induces respiratory depression in mice.2 Brorphine-d7 is regulated as a Schedule I compound in the United States. This product is intended for research and forensic applications.WARNING This product is not for human or veterinary use.

[1] NICOLEM. KENNEDY. Optimization of a Series of Mu Opioid Receptor (MOR) Agonists with High G Protein Signaling Bias[J]. Journal of Medicinal Chemistry, 2018, 61 19: 8895-8907. DOI: 10.1021/acs.jmedchem.8b01136
[2] MARTHE M. VANDEPUTTE . Elucidating the harm potential of brorphine analogues as new synthetic opioids: Synthesis, in vitro, and in vivo characterization[J]. Neuropharmacology, 2024, 260: Article 110113. DOI: 10.1016/j.neuropharm.2024.110113